NCT03633162 Maternal Grandmothers in the Born in Guangzhou Cohort Study
| NCT ID | NCT03633162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Condition | Hereditary Transmission |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2018-05-21 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2018-05-21 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The MGBIG is a study exploring cross-generational effects in 5000 women and their children and grandchildren located in Guangzhou, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology and on explaining the cause of the disease from the perspective of "grandmother-mother-child" heredity. Data are collected regarding environmental exposures, lifestyle, and social support on grandmother from birth to old age. Biological samples including blood and tissue samples are collected.
Eligibility Criteria
Inclusion Criteria: 1. Maternal Grandmother' grandchildren delivered in Guangzhou Women and Children's Medical Center 2. Baseline information of maternal grandmother's daughter during pregnancy available Exclusion Criteria: 1. Significant cardiovascular abnormalities 2. Intelligent obstacle, intellectual disabilities or gawkish condition
Contact & Investigator
Xiu Qiu, PhD
PRINCIPAL INVESTIGATOR
Guangzhou Women and Children's Medical Center, China
Frequently Asked Questions
Who can join the NCT03633162 clinical trial?
This trial is open to female participants only, aged 36 Years or older, up to 100 Years, studying Hereditary Transmission. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03633162 currently recruiting?
Yes, NCT03633162 is actively recruiting participants. Contact the research team at qxiu0161@163.com for enrollment information.
Where is the NCT03633162 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT03633162 clinical trial?
NCT03633162 is sponsored by Guangzhou Women and Children's Medical Center. The principal investigator is Xiu Qiu, PhD at Guangzhou Women and Children's Medical Center, China. The trial plans to enroll 5,000 participants.